Taiwan Liposome Company, Ltd. #IPO Preview ($TLC)
Company: Taiwan Liposome Company, Ltd. Symbol: TLC Description: They are a clinical-stage specialty pharmaceutical company dedicated to the development and commercialization of best-in-class novel nanomedicines that combine our proprietary lipid-assembled drug delivery platform with approved active pharmaceutical ingredients (APIs). Trade Date: 4/26 Shares: 4.7 million ($35m cash raise) Price Range: $7.46-$7.46 Underwriter(s): Cantor Co-Manager(s): CLSA,[…]
